Navigation Links
Record Venture Capital and Heated Deal Environment Propel Global Biotechnology Industry Forward in 2007
Date:5/19/2008

Ernst & Young's 2008 Global Biotechnology Report reveals robust investment

in the industry; sweeping trends that are transforming the industry

BOSTON, May 20 /PRNewswire/ -- The global biotechnology industry achieved record levels in financing and deal making in 2007, as investors and strategic partners showed strong confidence in the sector amid tightening global financial conditions that will continue to test the industry in 2008. These and other findings were highlighted in Beyond Borders: Global Biotechnology Report 2008, Ernst & Young's annual report on the trends shaping the biotechnology industry, released today.

"In 2007, investors were drawn to the tremendous value of biotech's innovation, with impressive results, as venture financing and deal making reached unprecedented heights," said Glen Giovannetti, Ernst & Young's Global Biotechnology Leader. "To continue its multi-year track record of progress, the industry must meet the current challenges of cooling public equity markets, greater regulatory scrutiny and higher product approval and reimbursement hurdles with fiscal discipline and the creativity and innovation for which it is known."
Key industry findings described in the report include:

-- The global biotechnology industry had a very strong year on the

financing front. Companies in the Americas and Europe raised more than

US$29.9 billion -- a new high excluding the outlier genomics bubble

year of 2000.

-- Venture financing reached an all-time high in 2007 with investment

totaling about US$7.5 billion, fueled by a record total of US$5.5

billion in the US and 72% growth in Canada.

-- Global public biotechnology company revenue rose by 8% in 2007,

crossing the US$80 billion threshold for the first time. Absent the

acquisition of several leading biotech revenue producers by big pharma,

revenue would have increased by about 17% -- i
'/>"/>

SOURCE Ernst & Young
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. New efficiency record for solar cells
2. First electrophysical recording of sleep in a wild animal
3. China Sky One Medical, Inc. Announces Record First Quarter 2008 Results
4. ATS Medical Announces Record Quarterly Revenue and Gross Profit
5. Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance
6. Dilon Technologies Closes First Quarter With Record Sales
7. Bioscience Career Fair in San Francisco Projected to Break Job Seeker Attendance Records
8. Laureate Pharma Reports Record Growth for 2007
9. Bioscience Career Fair in San Diego Expected to Draw Record Jobseeker Attendance
10. China Pharma Holdings, Inc. Announces Record 2007 Year End Results
11. Photonic Products Group, Inc. Reports Record Financial Results for FY 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 A study ... win races on the Formula 1 track could help ... collaboration between McLaren Applied Technologies (MAT), Stowhealth (a GP ... Suffolk is being funded by healthcare provider Simplyhealth. ... to collect data about the on-track performance of Vodafone ...
(Date:1/15/2014)... Rochester, NY (PRWEB) January 15, 2014 ... viruses can cause a major disease. One of these ... one of these diseases is rheumatoid arthritis (RA). Rheumatoid ... the body’s joints. As predicted by the theory, a ... EBV DNA in their bodies (1). , What ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... Date: Friday, April 11, 2014 , Time: 6 ... 1360 Almshouse Road, Warrington, Pa. , Details: ... solely dedicated to finding a cure for hepatitis B ... worldwide, will host its annual Crystal Ball on Friday, ... , Each year, the Crystal Ball attracts hundreds ...
Breaking Biology Technology:Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2
... SAN DIEGO, April 10 MedImmune today announced ... oncology,portfolio programs at the Annual Meeting of the ... commitment to,excellence in oncology research., "Cancer research ... at MedImmune and we,are proud to share data ...
... -- Sinovac Biotech Ltd. (Amex:,SVA), a leading provider ... General Meeting originally scheduled for March 25, 2008 ... During the April 8, 2008 Annual General ... Shangdi Xi Rd., Haidian District, Beijing,PRC, resolutions for ...
... CHICAGO, April 10 Advanced Life Sciences,Holdings, Inc. ... on a productive,meeting with the U.S. Food and ... New Drug Application (NDA) in the third quarter ... to treat mild-to-moderate,community acquired pneumonia (CAP)., (Logo: ...
Cached Biology Technology:MedImmune Presents Data Highlighting its Progressive Oncology Portfolio at Annual Meeting of the American Association For Cancer Research 2MedImmune Presents Data Highlighting its Progressive Oncology Portfolio at Annual Meeting of the American Association For Cancer Research 3Advanced Life Sciences Announces Plan to Submit NDA for Cethromycin 2Advanced Life Sciences Announces Plan to Submit NDA for Cethromycin 3
(Date:4/15/2014)... The global experts who study the deadliest infectious diseases ... G. Ksiazek, professors at the University of Texas Medical ... annual International Symposium on Filoviruses. The filoviruses include Ebola ... 90 percent of people infected. The current outbreak of ... than 100 deaths so far. , "This award ...
(Date:4/15/2014)... nanoparticle form could help reduce side effects by targeting ... scientists have developed nanoparticles that deliver one or two ... design particles that can carry any more than that ... devised a new way to build such nanoparticles, making ... drugs. In a paper published in the Journal ...
(Date:4/15/2014)... of Adelaide research into parasites of cuttlefish, squid ... astonishing life cycles, and shown how they may ... Researcher Dr Sarah Catalano has described 10 new ... the kidneys of cephalopods (cuttlefish, squid and octopus). ... to be described from Australian waters. , ...
Breaking Biology News(10 mins):International research group recognizes UTMB experts 2International research group recognizes UTMB experts 3Targeting cancer with a triple threat 2Targeting cancer with a triple threat 3Bizarre parasite may provide cuttlefish clues 2
... anti-cancer drugs block the enzymes that snip the kinks and ... cells but the drugs are increasingly encountering resistant bacteria ... Berkeley, biochemists could pave the way for new research into ... poisons for cancer cells and harmful bacteria. "The development ...
... foods is a top priority in tackling the obesity epidemic ... six months, the Institute of Medicine, United States Department of ... taken an interest in improving access to affordable and nutritious ... of epidemiology, and his team are tackling the same issue. ...
... Institute for Brain Science announced today that it has launched ... charting genes at work throughout the human brain. The ... extensive and detailed body of information about gene activity in ... or "turned on" where. In the coming years, the ...
Cached Biology News:Preventing cells from getting the kinks out of DNA 2Preventing cells from getting the kinks out of DNA 3Obesity remains an economic issue, Seattle obesity study finds 2Obesity remains an economic issue, Seattle obesity study finds 3Allen Institute for Brain Science launches Allen Human Brain Atlas 2Allen Institute for Brain Science launches Allen Human Brain Atlas 3
... The Zero Background Cloning Kit includes ... selection in E. coli. The pZErO-1 vector ... The small size of the Zeocin resistance ... increased ligation and transformation efficiencies. The kit ...
Polyethylene Glycol 8000, 1 kg. PEG 8000.Used in differential DNA precipitation. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Panomer 9 oligodeoxynucleotides are random primers that are labeled at the 5' end with our proprietary QSY 7 dye and they are useful for assessing microarray spot morphology, hybridization potential ...
Alkaline Phosphatase Stabilizer Solution, 1 L...
Biology Products: